Decibel Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$64.0M | −$50.2M | −$39.6M |
| Net income | −$63.0M | −$51.8M | −$39.3M |
| Total assets | $123.4M | $184.5M | $67.3M |
| Total liabilities | $41.6M | $42.8M | $29.0M |
| Equity | $81.8M | $141.7M | −$54.8M |
| EPS (diluted) | $-2.52 | $-2.49 | $-19.65 |
| Shares out. | 25.0M | 25.0M | 521,052 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −77.0%
- Return on assets
- −51.1%
- Return on capital (ROCE)
- −63.4%
- Liabilities / assets
- 33.7%
- Debt / equity
- 0.51×
- Book value / share
- $3.28
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -4.20distress
- Accruals / assets
- −5.0%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Mclaughlin Kevin FDirector | Sep 25, 2023 | D | 5,000 | — |
| Reid LaurenceOfficer — See Remarks | Sep 25, 2023 | D | 220,849 | — |
| Kapusta Matthew CDirector | Sep 25, 2023 | D | 10,000 | — |
| Nochur SaraDirector | Sep 25, 2023 | D | 5,000 | — |
| Nochur SaraDirector | Jun 13, 2023 | Grant | 5,000 | $0.00 |
| Carson William H.Director | Jun 13, 2023 | Grant | 5,000 | $0.00 |
| Finger Alison CecilyDirector | Jun 13, 2023 | Grant | 5,000 | $0.00 |
| Mclaughlin Kevin FDirector | Jun 13, 2023 | Grant | 5,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 25, 2023
- Other material eventAug 25, 2023
- Entered a material agreement · Other material eventAug 9, 2023
- Shareholder voteJun 13, 2023
- Amended charter or bylawsApr 6, 2023
- Director / officer changeMar 21, 2023
- Regulation FD disclosureMar 13, 2023
- Regulation FD disclosureJan 9, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2024
- 15-12GOct 10, 2023
- EFFECTOct 6, 2023
- SC 13D/ASep 27, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- 4FORM 4 SUBMISSIONSep 25, 2023
- S-8 POSSep 25, 2023
- S-8 POSSep 25, 2023
- S-8 POSSep 25, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.